Are ministerial recommendations sufficient to avoid bisphosphonate related osteonecrosis of the jaw? A case report
Bisphosphonate related osteonecrosis of the jaw (BRONJ) can occur in patients affected by malignancy associated hypercalcemia, bone metastases of solid tumors or multiple myeloma intaking amino-bisphosphonates or other bone resorption inhibitors.
Saved in:
Main Authors: | A. Massaria (Author), M.V. Bartolucci (Author), R. Baldi (Author), M. Messi (Author) |
---|---|
Format: | Book |
Published: |
Publymed,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bisphosphonates and osteonecrosis of jaws
by: Geetha Vijay, et al.
Published: (2012) -
Bisphosphonate-related osteonecrosis of the jaw: An insight
by: Shalini Kapoor, et al.
Published: (2013) -
Bisphosphonate-related osteonecrosis of the jaw: specificities
by: Siri Paulo, et al.
Published: (2014) -
Osteonecrosis of the Jaws in Treatment with Bisphosphonates
by: M. Machálka, et al.
Published: (2006) -
Bisphosphonate-associated osteonecrosis of the jaws
by: Rajiv S Desai, et al.
Published: (2012)